Literature DB >> 7016741

Clearance and tissue uptake of immune complexes in complement-depleted and control mice.

B Bockow, M Mannik.   

Abstract

The clearance kinetics, specific hepatic uptake and specific splenic uptake of immune complexes were examined in control mice and in mice treated with large doses of purified cobra venom factor (CoF) to deplete serum C3. At least 90% depletion of C3 was achieved as tested by double diffusion with antiserum specific to antigenic determinants on C3. A saturating dose of preformed immune complexes, consisting of HSA and rabbit antibodies to HSA, was used in these experiments. No differences in clearance kinetics and organ uptake of the immune complexes containing IgG as antibodies were observed between the two groups of mice. Within the limits of the experimental system no evidence was obtained for the participation of serum C3 and C3b receptors on Kupffer cells in the hepatic uptake of circulating immune complexes. The apparent discrepancies on the role of C3 and C3b receptors between these experiments and the in vitro studies on the uptake of immune complexes by macrophages is most likely related to the differences in the lattice of immune complexes employed by investigators.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7016741      PMCID: PMC1458264     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  23 in total

1.  Effect of cortisone on the disappearance kinetics and tissue localization of soluble immune complexes.

Authors:  A O Haakenstad; J B Case; M Mannik
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

2.  MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION.

Authors:  M R MARDINEY; H J MUELLER-EBERHARD
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

3.  Reaction mechanism of the alternative pathway of complement fixation.

Authors:  P J Lachmann; P Nicol
Journal:  Lancet       Date:  1973-03-03       Impact factor: 79.321

4.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

5.  Saturation of the reticuloendothelial system with soluble immune complexes.

Authors:  A O Haakenstad; M Mannik
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

6.  Studies on antigen-antibody complexes. II. Quantification of tissue uptake of soluble complexes in normal and complement-depleted rabbits.

Authors:  W P Arend; M Mannik
Journal:  J Immunol       Date:  1971-07       Impact factor: 5.422

7.  Evaluation of immunological specificity of flurescein-conjugated antisera with agarose-antigen sections.

Authors:  J B Case; L M Lussier; M Mannik
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

8.  Molecular composition and sedimentation characteristics of soluble antigen-antibody complexes.

Authors:  W P Arend; D C Teller; M Mannik
Journal:  Biochemistry       Date:  1972-10-24       Impact factor: 3.162

9.  Cobra venom factor: evidence for its being altered cobra C3 (the third component of complement).

Authors:  C A Alper; D Balavitch
Journal:  Science       Date:  1976-03-26       Impact factor: 47.728

10.  In vitro adherence of soluble immune complexes to macrophages.

Authors:  W P Arend; M Mannik
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

View more
  21 in total

1.  Prolonged circulation of immune complexes due to various altered immune functions contributes to nephritis in MRL/lpr mice.

Authors:  N A Granholm; T Cavallo
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Lipopolysaccharide from gram-negative bacteria enhances polyclonal B cell activation and exacerbates nephritis in MRL/lpr mice.

Authors:  T Cavallo; N A Granholm
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

3.  Demonstration of hepatic Fc receptor function in vivo.

Authors:  N Yousaf; J C Howard; B D Williams
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

4.  Repeated exposure to bacterial lipopolysaccharide interferes with disposal of pathogenic immune complexes in mice.

Authors:  T Cavallo; N A Granholm
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

5.  Factor VIII associated with lipidic nanoparticles retains efficacy in the presence of anti-factor VIII antibodies in hemophilia A mice.

Authors:  Krithika A Shetty; Matthew P Kosloski; Donald E Mager; Sathy V Balu-Iyer
Journal:  Biopharm Drug Dispos       Date:  2016-09-13       Impact factor: 1.627

6.  Immune complex processing in C1q-deficient mice.

Authors:  J T Nash; P R Taylor; M Botto; P J Norsworthy; K A Davies; M J Walport
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

7.  Clearance kinetics and organ uptake of complement-solubilized immune complexes in mice.

Authors:  M T Aguado; M Mannik
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

8.  Studies on rheumatoid factor: I. The effect of rheumatoid factor on the clearance of preformed immune complexes in mice.

Authors:  D N Hogben; M E Devey
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

9.  Studies in cobra venom factor treated rats of antibody coated erythrocyte clearance by the spleen: differential influence of red blood cell antigen number on the inhibitory effects of immune complexes on Fc dependent clearance.

Authors:  N Yousaf; J C Howard; B D Williams
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

10.  Scintigraphic distribution of complexes of antiinsulin antibodies and 123I-insulin. In vivo studies in rats.

Authors:  F Sodoyez-Goffaux; J C Sodoyez; M Koch; N Dozio; E R Arquilla; B McDougall; C J De Vos; R von Frenckell
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.